Sandra Rayego-Mateos

23PUBLICATIONS
37CO-AUTHORS
Molecular targetsPredictive and prognostic markersHaematologyCardiology (incl. cardiovascular diseases)Immunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Aug 14, 2025
STING inhibition alleviates experimental peritoneal damage: potential therapeutic relevance for peritoneal dialysis.

Vanessa Marchant, Jorge García-Giménez, Guadalupe T González-Mateo

|Jun 27, 2025
Dasatinib and Quercetin Combination Increased Kidney Damage in Acute Folic Acid-Induced Experimental Nephropathy.

Antonio Battaglia-Vieni, Vanessa Marchant, Lucia Tejedor-Santamaria

|Dec 23, 2023
BET Protein Inhibitor JQ1 Ameliorates Experimental Peritoneal Damage by Inhibition of Inflammation and Oxidative Stress.

Vanessa Marchant, Flavia Trionfetti, Lucia Tejedor-Santamaria

|Aug 31, 2023
STING1 deficiency ameliorates immune-mediated crescentic glomerulonephritis in mice.

Jorge García-Giménez, Gina Córdoba-David, Sandra Rayego-Mateos

|Aug 26, 2023
CCN2 Activates RIPK3, NLRP3 Inflammasome, and NRF2/Oxidative Pathways Linked to Kidney Inflammation.

Sandra Rayego-Mateos, Laura Marquez-Exposito, Pamela Basantes

|Aug 09, 2023
Intravascular hemolysis triggers NAFLD characterized by a deregulation of lipid metabolism and lipophagy blockade.

Sandra Rayego-Mateos, José Luis Morgado-Pascual, Cristina García-Caballero

Pageof 4

Frequent Collaborators

17 joint publications

Marta Ruiz-Ortega

12 joint publications

Alberto Ortiz

8 joint publications

Vanessa Marchant

8 joint publications

Raul Rodrigues-Diez